Cargando…

Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding

Beta-2-glycoprotein I (β2GPI) is a blood protein and the major antigen in the autoimmune disorder antiphospholipid syndrome (APS). β2GPI exists mainly in closed or open conformations and comprises of 11 disulfides distributed across five domains. The terminal Cys288/Cys326 disulfide bond at domain V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchholz, Ina, McDonnell, Thomas, Nestler, Peter, Tharad, Sudarat, Kulke, Martin, Radziszewska, Anna, Ripoll, Vera M., Schmidt, Frank, Hammer, Elke, Toca-Herrera, Jose L., Rahman, Anisur, Delcea, Mihaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907366/ https://www.ncbi.nlm.nih.gov/pubmed/33633190 http://dx.doi.org/10.1038/s41598-021-84021-2

Ejemplares similares

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Protein-Lipid Interaction of Cytolytic Toxin Cyt2Aa2 on Model Lipid Bilayers of Erythrocyte Cell Membrane
por: Tharad, Sudarat, et al.
Publicado: (2020)

Drug-induced activation of integrin alpha IIb beta 3 leads to minor localized structural changes
por: Janke, Una, et al.
Publicado: (2019)

Bacillus thuringiensis Cyt2Aa2 toxin disrupts cell membranes by forming large protein aggregates
por: Tharad, Sudarat, et al.
Publicado: (2016)

Cholesterol Increases Lipid Binding Rate and Changes Binding Behavior of Bacillus thuringiensis Cytolytic Protein
por: Tharad, Sudarat, et al.
Publicado: (2018)

Mutation of a Threonine Residue in αD-β4 Loop of Cyt2Aa2 Protein Influences Binding on Fluid Lipid Membranes
por: Tangsongcharoen, Chontida, et al.
Publicado: (2023)

Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
por: McDonnell, Thomas, et al.
Publicado: (2015)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
por: McDonnell, Thomas C. R., et al.
Publicado: (2018)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
por: Bourke, Lauren T, et al.
Publicado: (2017)

PEGylated drugs in rheumatology—why develop them and do they work?
por: McDonnell, Thomas, et al.
Publicado: (2014)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli
por: Ioannou, Yiannis, et al.
Publicado: (2006)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Going viral in rheumatology: using social media to show that mechanistic research is relevant to patients with lupus and antiphospholipid syndrome
por: McDonnell, Thomas C R, et al.
Publicado: (2018)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Unveiling the N-Terminal Homodimerization of BCL11B by Hybrid Solvent Replica-Exchange Simulations
por: Schulig, Lukas, et al.
Publicado: (2021)

A Hypothesized Mechanism for Chronic Pancreatitis Caused by the N34S Mutation of Serine Protease Inhibitor Kazal-Type 1 Based on Conformational Studies
por: Kulke, Martin, et al.
Publicado: (2021)

Flexible global working arrangements: An integrative review and future research agenda
por: Jooss, Stefan, et al.
Publicado: (2020)

Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up
por: Farinha, Filipa, et al.
Publicado: (2020)

The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant
por: Buchholz, Ina, et al.
Publicado: (2020)

Structural and Biophysical Insights into SPINK1 Bound to Human Cationic Trypsin
por: Nagel, Felix, et al.
Publicado: (2022)

Predicting Binding to P-Glycoprotein by Flexible Receptor Docking
por: Dolghih, Elena, et al.
Publicado: (2011)

On the Origin of Large Flexibility of P-glycoprotein in the Inward-facing State
por: Wen, Po-Chao, et al.
Publicado: (2013)

Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015)

GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEIN
por: Alper, Chester A., et al.
Publicado: (1972)

Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
por: Poulton, Katie, et al.
Publicado: (2015)

Atomic Force Microscopy Meets Biophysics, Bioengineering, Chemistry, and Materials Science
por: Toca‐Herrera, José L.
Publicado: (2019)

Preservation of whole antibodies within ancient teeth
por: Shaw, Barry, et al.
Publicado: (2023)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Thermal sensitivity and flexibility of the Cε3 domains in immunoglobulin E
por: Doré, Katy A., et al.
Publicado: (2017)

Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation
por: Meesaragandla, Brahmaiah, et al.
Publicado: (2020)

Identification of Kazal Inhibitor Scaffolds with Identical Canonical Binding Loops and Their Effects on Binding Properties
por: Nagel, Felix, et al.
Publicado: (2023)

Characterization of Cell Scaffolds by Atomic Force Microscopy
por: Iturri, Jagoba, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jigcsjarj0vfra9jsqc3snon4g